The prevalence of cardiovascular disease and antidiabetes treatment characteristics among a large type 2 diabetes population in the United States

by Wayne Weng, Ye Tian, Sheldon X. Kong, Rahul Ganguly, Malene Hersloev, Jason Brett, Todd Hobbs
Published 2019-07-01

Impact of atherosclerotic cardiovascular disease on healthcare resource utilization and costs in patients with type 2 diabetes mellitus in a real-world setting

by Wayne Weng, Ye Tian, Sheldon X. Kong, Rahul Ganguly, Malene Hersloev, Jason Brett, Todd Hobbs
Published 2020-03-01

The prevalence of cardiovascular disease by vascular bed and impact on healthcare costs in a large, real‐world population with type 2 diabetes

by Wayne Weng, Sheldon X. Kong, Rahul Ganguly, Malene Hersloev, Jason Brett, Todd Hobbs, Florian M.M. Baeres
Published 2020-04-01